136 related articles for article (PubMed ID: 9210508)
61. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
[TBL] [Abstract][Full Text] [Related]
62. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies.
Yoshino T; Nakase H; Ueno S; Uza N; Inoue S; Mikami S; Matsuura M; Ohmori K; Sakurai T; Nagayama S; Hasegawa S; Sakai Y; Chiba T
Inflamm Bowel Dis; 2007 Dec; 13(12):1516-21. PubMed ID: 17828781
[TBL] [Abstract][Full Text] [Related]
63. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.
Toyoda M; Carlos JB; Galera OA; Galfayan K; Zhang X; Sun Z; Czer LS; Jordan SC
Transplantation; 1997 Apr; 63(7):957-63. PubMed ID: 9112347
[TBL] [Abstract][Full Text] [Related]
64. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC
Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031
[TBL] [Abstract][Full Text] [Related]
65. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation.
Slifkin M; Ruthazer R; Freeman R; Bloom J; Fitzmaurice S; Fairchild R; Angelis M; Cooper J; Barefoot L; Rohrer R; Snydman DR
Liver Transpl; 2005 Dec; 11(12):1597-602. PubMed ID: 16315314
[TBL] [Abstract][Full Text] [Related]
66. Comparison of serology, antigenemia assay and the polymerase chain reaction for monitoring active cytomegalovirus infections in hematopoietic stem cell transplantation patients.
Bonon SH; Rossi CL; de Souza CA; Vigorito AC; Costa SC
Rev Inst Med Trop Sao Paulo; 2006; 48(5):275-8. PubMed ID: 17086316
[TBL] [Abstract][Full Text] [Related]
67. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
Härmä M; Loginov R; Piiparinen H; Halme L; Höckerstedt K; Lautenschlager I
Transplant Proc; 2005 Mar; 37(2):1230-2. PubMed ID: 15848678
[TBL] [Abstract][Full Text] [Related]
68. Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study Group.
Salmon-Céron D; Fillet AM; Aboulker JP; Gérard L; Houhou N; Carrière I; Ostinelli J; Vildé JL; Brun-Vézinet F; Leport C
Clin Infect Dis; 1999 Apr; 28(4):901-5. PubMed ID: 10825058
[TBL] [Abstract][Full Text] [Related]
69. Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation.
Aitken C; Barrett-Muir W; Millar C; Templeton K; Thomas J; Sheridan F; Jeffries D; Yaqoob M; Breuer J
J Clin Microbiol; 1999 Sep; 37(9):2804-7. PubMed ID: 10449456
[TBL] [Abstract][Full Text] [Related]
70. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture.
Boeckh M; Gallez-Hawkins GM; Myerson D; Zaia JA; Bowden RA
Transplantation; 1997 Jul; 64(1):108-13. PubMed ID: 9233710
[TBL] [Abstract][Full Text] [Related]
71. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
[TBL] [Abstract][Full Text] [Related]
72. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
[TBL] [Abstract][Full Text] [Related]
73. CMV infection, diagnosis and antiviral strategies after liver transplantation.
Lautenschlager I
Transpl Int; 2009 Nov; 22(11):1031-40. PubMed ID: 19619175
[TBL] [Abstract][Full Text] [Related]
74. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
Hebart H; Müller C; Löffler J; Jahn G; Einsele H
Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
[TBL] [Abstract][Full Text] [Related]
75. Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report.
Nawashiro Y; Shiraki K; Yamamoto S; Takizawa K; Sasada Y; Suehiro M; Miura K; Hattori M; Daikoku T; Hisano M
Transplant Proc; 2018 Dec; 50(10):3932-3936. PubMed ID: 30577289
[TBL] [Abstract][Full Text] [Related]
76. A short-term preemptive treatment for cytomegalovirus infection in seropositive patients after liver transplantation.
Dahiya D; Lee CF; Chan KM; Wu TJ; Chou HS; Cheng SS; Lee WC
J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):32-8. PubMed ID: 20499109
[TBL] [Abstract][Full Text] [Related]
77. [Should recurrent Cytomegalovirus infections in patients with liver transplantation be treated?].
Tarp BD; Astrup LB
Ugeskr Laeger; 1997 May; 159(22):3413-6. PubMed ID: 9199030
[TBL] [Abstract][Full Text] [Related]
78. [Cytomegaloviral infection in patients with hemoblastoses].
Savchenko VG; Troitskaia VV; Misiurin AV; Parovichnikova VN; Isaev VG; Mendeleeva LP; Liubimova LS; Demidova IA; Aksenova EV; Filatov FP
Ter Arkh; 2003; 75(7):52-8. PubMed ID: 12934482
[TBL] [Abstract][Full Text] [Related]
79. Clinical use of immunohistopathologic methods for the diagnosis of cytomegalovirus hepatitis in human liver allograft biopsy specimens.
Barkholt LM; Ehrnst A; Veress B
Scand J Gastroenterol; 1994 Jun; 29(6):553-60. PubMed ID: 8079116
[TBL] [Abstract][Full Text] [Related]
80. Localization of cytomegalovirus antigens in liver allografts over time.
Theise ND; Conn M; Thung SN
Hum Pathol; 1993 Jan; 24(1):103-8. PubMed ID: 8380273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
